相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+breast cancer
X. He et al.
ANNALS OF ONCOLOGY (2012)
Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
Navid Sadeghi et al.
CLINICAL CANCER RESEARCH (2012)
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications
C. Grimaldi et al.
LEUKEMIA (2012)
Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients
X. -X. He et al.
ANNALS OF ONCOLOGY (2011)
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents
Pamela J. Goodwin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth
Yin-Hsun Feng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements
I. R. F. van Berlo-van de Laar et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2011)
Long-term use of insulin glargine might increase the risk of breast cancer
Carol Wilson
Nature Reviews Endocrinology (2011)
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Sreenivasa Rao Kondapally Seshasai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Metformin: Multi-faceted protection against cancer
Sonia Del Barco et al.
ONCOTARGET (2011)
Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture
Pasha Apontes et al.
ONCOTARGET (2011)
Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF-κB Pathway and Generation of Reactive Oxygen Species
Yanli Jin et al.
CANCER RESEARCH (2010)
The AMPK-FoxO3A axis as a target for cancer treatment
Fulvio Chiacchiera et al.
CELL CYCLE (2010)
The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy
Stephen L. Abrams et al.
CELL CYCLE (2010)
Diabetes and Cancer A consensus report
Edward Giovannucci et al.
DIABETES CARE (2010)
Insulin glargine and insulin have identical effects on proliferation and phosphatidylinositol 3-kinase/AKT signalling in rat thyrocytes and human follicular thyroid cancer cells
K. Mueller et al.
DIABETOLOGIA (2010)
Metronomic chemotherapy: new rationale for new directions
Eddy Pasquier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Treatment with insulin glargine (Lantus®) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells
Doris Mayer et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2010)
Insulin Glargine and NPH Insulin Increase to a Similar Degree Epithelial Cell Proliferation and Aberrant Crypt Foci Formation in Colons of Diabetic Mice
Jutta M. Nagel et al.
Hormones & Cancer (2010)
Activity of triptolide against human mast cells harboring the kinase domain mutant KIT
Yanli Jin et al.
CANCER SCIENCE (2009)
Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARγ-dependent and PPARγ-independent pathways
Besstina E. Lyles et al.
CELL CYCLE (2009)
Triptolide Inhibits Bcr-Abl Transcription and Induces Apoptosis in STI571-resistant Chronic Myelogenous Leukemia Cells Harboring T315I Mutation
Xianping Shi et al.
CLINICAL CANCER RESEARCH (2009)
Combined randomised controlled trial experience of malignancies in studies using insulin glargine
P. D. Home et al.
DIABETOLOGIA (2009)
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden
J. M. Jonasson et al.
DIABETOLOGIA (2009)
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
H. M. Colhoun
DIABETOLOGIA (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
L. G. Hemkens et al.
DIABETOLOGIA (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor γ involves angiogenesis inhibition
Yu-Wei Dong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Roles of p53, Myc and HIF-1 in Regulating Glycolysis - the Seventh Hallmark of Cancer
S. J. Yeung et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Proliferation of Colo-357 pancreatic carcinoma cells and survival of patients with pancreatic carcinoma are not altered by insulin glargine
Saskia Erbel et al.
DIABETES CARE (2008)
Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and IGF-I
E. Liefvendahl et al.
HORMONE AND METABOLIC RESEARCH (2008)
Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells
Efstathia Papageorgiou et al.
MOLECULAR MEDICINE (2008)
Metformin induces apoptosis of pancreatic cancer cells
Luo-Wei Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling
Giulia Cantini et al.
PPAR RESEARCH (2008)
Proliferative effects of insulin analogues on mammary epithelial cells
Doris Mayer et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells
Ryan J. O. Dowling et al.
CANCER RESEARCH (2007)
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Monica Buzzai et al.
CANCER RESEARCH (2007)
Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysis
Lonneke V. van de Poll-Franse et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis
A. Isakovic et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation
Jingxuan Pan et al.
BLOOD (2007)
Increased PTEN expression due to transcriptional activation of PPARγ by Lovastatin and Rosiglitazone
RE Teresi et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Peroxisome proliferator-activated receptor-γ figands for the treatment of breast cancer
MH Fenner et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer
LC Richardson et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate/cytarabine regimen
MA Weiser et al.
CANCER (2004)
Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults
SS Coughlin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Gemfibrozil considerably increases the plasma concentrations of rosiglitazone
M Niemi et al.
DIABETOLOGIA (2003)
Mortality from site-specific malignancies in type 2 diabetic patients from Verona
G Verlato et al.
DIABETES CARE (2003)
Impact of diabetes mellitus on outcomes in patients with colon cancer
JA Meyerkardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Activation of PPARγ increases PTEN expression in pancreatic cancer cells
B Farrow et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study
PJ Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Postload plasma glucose concentration and 27-year prostate cancer mortality (United States)
SM Gapstur et al.
CANCER CAUSES & CONTROL (2001)
Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis
TIL Nilsen et al.
BRITISH JOURNAL OF CANCER (2001)
分享论文
